Ne
Neumedicines
Pasadena CAFounded 200310 employees
Private CapbiotechPrivateHematology
Platform: HemaMax Rad
Market Cap
N/A
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| NEU-3101 | NEU-3101 | NDA/BLA | 1 | GIP-R | Asthma | ||
| Teravorutinib | NEU-975 | Phase 1/2 | 1 | TYK2 | CLL | ||
| Zanufotisoran | NEU-4376 | Phase 1/2 | 2 | ALK | DLBCLTTR Amyloidosis |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (2)